News Verona Pharma Announces the US FDA has Accepted the New Drug Application Filing for Ensifentrine for the Maintenance Treatment of COPD Continue Reading Previous Letter to Shareholders and Corporate UpdateNext Oxurion Announces Key Amendments to Atlas and Kreos/Pontifax Agreements Enabling KALAHARI Trial to Progress to Topline Results in 2023 Related Stories News Former Depop, Etsy and Missguided Marketing Leader Launches Specialist SEO and PPC Agency – VKNG Digital for Lancashire Businesses News SourcingGPT Revolutionizes Trade Show Sourcing at Eletrolar Show 2026 News Micware Commences Full-Scale Spatial Intelligence Business for the Web4 Era News ThriveCart Launches Customer Advisory Council to Strengthen Transparency and Product Direction News Data I/O Proposes to Acquire Embedded Software Security Assets from IAR News KIT WAN STUDIOS to shine on the CENTRESTAGE ELITES runway this September